Critchley-Thorne et al. have evaluated the effectiveness of IFNG in peripheral blood lymphocytes from breast cancer patients and detected diminished IFN-γ-induced signaling in B cells of these patients in spite of normal signaling in T cells or natural killer cells [13]. This evidence concerns the gene IFNG and breast carcinoma.